Cancer News and Research

Latest Cancer News and Research

NJHA honors professionals and organizations for sustainable healthcare

Several individuals and organizations were honored at the 91st Annual Meeting of the New Jersey Hospital Association today at the Hyatt Regency Princeton.

23 Jan 2010

Study: Warburg effect promotes rapid cell proliferation and tumor growth

A team of scientists led by Professor Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory has discovered molecular factors in cancer cells that boost the production of an enzyme that helps alter the cells' glucose metabolism. The altered metabolic state, called the Warburg effect, promotes extremely rapid cell proliferation and tumor growth. Adrian Krainer, Ph.D.

23 Jan 2010

NCMHD awards Weill Cornell Medical College $8M for establishing CEDREC in New York City

Weill Cornell Medical College has established a new research center to improve medical care in ethnically diverse and medically underserved communities in New York City.

23 Jan 2010

Pfizer reports final results from randomized Phase 3 trial of Sutent

Pfizer Inc. today announced final results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic neuroendocrine tumors, a type of cancer which originates in the hormone-producing area of the pancreas.

23 Jan 2010

Health IT roundup: Provider-vendor relationships an issue, group uses racial info to customize care

Health News Florida/Kaiser Health News: "A group of Broward County doctors looking to switch to electronic medical records say the result has been a massive headache: surprise charges, inadequate training and even blocked access to patient files."

23 Jan 2010

HSV-2 can reactivate throughout the genital tract

Genital herpes caused by a reactivation of herpes simplex virus type 2 (HSV-2) is generally treated as a lesion in one specific area of the genital region. A new study, however, finds that the virus can frequently reactivate throughout the genital tract, an important new concept that could help guide both HSV-2 treatment and prevention.

23 Jan 2010

IsoRay expands market awareness program by joining www.StockProfile.com

IsoRay, Inc., announced today that they have expanded their market awareness program by joining www.StockProfile.com, a customized web-based platform showcasing emerging growth stocks.

23 Jan 2010

Sutter Health deploys surgical care team and sends medical supplies and equipment for Haiti relief efforts

A 15-member surgical care team from the Sutter Health network deployed Thursday from San Francisco International Airport to provide critical medical care to earthquake victims in Haiti. The team included general and orthopedic surgeons, anesthesiologists, pulmonary acute care specialists and operating room nurses from Sutter Health-affiliated Alta Bates Summit Medical Center, California Pacific Medical Center and Mills-Peninsula Health Services.

23 Jan 2010

USPTO issues new patent for Advaxis' intellectual property portfolio

The U.S. Patent and Trademark Office (USPTO) issued today patent 7,635,479, "Compositions and Methods for Enhancing the Immunogenicity of Antigens,” by Dr. Yvonne Paterson, et al, which is assigned to the Trustees of the University of Pennsylvania and licensed to Advaxis, Incorporated (OTCBB: ADXS).

22 Jan 2010

Study shows certain heart medications may decrease risk of Parkinson's disease

UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease.

22 Jan 2010

Access Pharmaceuticals to sell 2.10M shares in registered direct offering

ACCESS PHARMACEUTICALS, INC., today announced that it has entered into definitive agreements with accredited investors to sell in a registered direct offering an aggregate of 2.10 million shares of its common stock at a price of $3.00 per share for aggregate gross proceeds of $6.3 million.

22 Jan 2010

Data from GenVec's trial in esophageal cancer showcased at 2010 Gastrointestinal Cancer Symposium

GenVec, Inc. announced today that data from the Company's trial in esophageal cancer were presented at the American Society of Clinical Oncology's 2010 Gastrointestinal Cancer Symposium in Orlando, Florida on January 22, 2010.

22 Jan 2010

Democrats struggle to revamp health reform strategy

Efforts to save the reform effort were teetering "on the brink of collapse Thursday as House and Senate leaders struggled to coalesce around a strategy to rescue the plan," Politico reports.

22 Jan 2010

Curis prices registered direct offering

Curis, Inc. announced today that it has priced a registered direct offering of 6,449,288 units, at a price of $2.52 per unit, for gross proceeds of $16.25 million before deducting placement agents’ fees and estimated offering expenses. Each unit consists of one share of the company's common stock and a warrant to buy 0.25 of a share of the company's common stock. The warrants will be exercisable for a period of five years beginning on the date of issuance, at an exercise price of $3.55 per share.

22 Jan 2010

NIH awards grants to develop new tobacco-related drug therapies

Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.

22 Jan 2010

Tips to make healthy lifestyle changes

As January comes to a close, will your New Year's resolution end with it? If you find yourself struggling to keep your resolution, you're not alone, says William Manard, M.D., Saint Louis University assistant professor of family and community medicine.

22 Jan 2010

Benefits of DNA testing

Does the term “genetic testing” conjure up thoughts of cloned, robot-like human beings and malevolent plots to rule the world? If so, you’ve been reading too much science fiction! The truth is, DNA testing has been put to very beneficial use for decades, primarily in the medical, law enforcement, and legal fields.

22 Jan 2010

ACS Chemical Biology report supports zebrafish for drug development

By combining the tools of medicinal chemistry and zebrafish biology, a team of Vanderbilt investigators has identified compounds that may offer therapeutic leads for bone-related diseases and cancer.

22 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

PDL Biopharma presents federal income tax information for 2009 dividend payments

PDL BioPharma, Inc. today announced the allocation between dividend income and return of capital for federal income tax purposes for dividends paid in 2009.

22 Jan 2010